Rowlandmiller & Partners’s Thermo Fisher Scientific TMO Stock Holding History

Rowlandmiller & Partners’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$145K	Buy	289 +25	+9%	+$12K	0.03%	173
2026 Q1	$130K	Hold	264	–	–	0.03%	178
2025 Q4	$153K	Hold	264	–	–	0.03%	169
2025 Q3	$128K	Hold	264	–	–	0.03%	176
2025 Q2	$107K	Hold	264	–	–	0.02%	181
2025 Q1	$131K	Hold	264	–	–	0.03%	164
2024 Q4	$137K	Buy	264 +30	+13%	+$16.5K	0.03%	162
2024 Q3	$145K	Hold	234	–	–	0.03%	156
2024 Q2	$129K	Hold	234	–	–	0.03%	158
2024 Q1	$136K	Hold	234	–	–	0.03%	158
2023 Q4	$124K	Hold	234	–	–	0.03%	163
2023 Q3	$118K	Sell	234 -4	-2%	-$2.13K	0.03%	161
2023 Q2	$124K	Buy	238 +4	+2%	+$2.16K	0.03%	168
2023 Q1	$135K	Hold	234	–	–	0.03%	162
2022 Q4	$129K	Hold	234	–	–	0.03%	163
2022 Q3	$119K	Buy	234 +4	+2%	+$2.24K	0.03%	162
2022 Q2	$125K	Hold	230	–	–	0.03%	159
2022 Q1	$136K	Hold	230	–	–	0.03%	158
2021 Q4	$153K	Buy	+230	New	+$144K	0.03%	157
2021 Q3	–	Sell	-230	Closed	-$116K	–	183
2021 Q2	$116K	Hold	230	–	–	0.03%	169
2021 Q1	$105K	Hold	230	–	–	0.03%	163
2020 Q4	$107K	Buy	+230	New	+$108K	0.03%	160

Other funds holding TMO

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return

Rowlandmiller & Partners's TMO Position: Q2 2026 in Review

Rowlandmiller & Partners increased its Thermo Fisher Scientific (TMO) stake by 9.5% in Q2 2026, buying an estimated $12K and bringing the position to 289 shares worth $145K. The position accounts for 0.03% of the portfolio, ranked #173.

Rowlandmiller & Partners first reported a position in TMO in Q4 2020 and has held it in 22 quarters since. The position peaked at $153K in Q4 2021. 1,172 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Rowlandmiller & Partners held 289 shares of Thermo Fisher Scientific worth $145K as of Q2 2026.
Rowlandmiller & Partners bought 25 Thermo Fisher Scientific shares in Q2 2026, an estimated $12K.
Thermo Fisher Scientific made up 0.03% of Rowlandmiller & Partners's portfolio in Q2 2026, its #173 holding.
Rowlandmiller & Partners first reported a position in Thermo Fisher Scientific in Q4 2020 and has held it in 22 quarters since.
Rowlandmiller & Partners's Thermo Fisher Scientific position peaked at $153K in Q4 2021.
1,172 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Rowlandmiller & Partners's 13F filing for Q2 2026, filed 23 Jul 2026.